279 related articles for article (PubMed ID: 7554139)
1. Matrix metalloproteinases and cardiovascular disease.
Dollery CM; McEwan JR; Henney AM
Circ Res; 1995 Nov; 77(5):863-8. PubMed ID: 7554139
[No Abstract] [Full Text] [Related]
2. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis.
George SJ
Curr Opin Lipidol; 1998 Oct; 9(5):413-23. PubMed ID: 9812195
[TBL] [Abstract][Full Text] [Related]
3. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
Butler GS; Will H; Atkinson SJ; Murphy G
Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases: a review.
Birkedal-Hansen H; Moore WG; Bodden MK; Windsor LJ; Birkedal-Hansen B; DeCarlo A; Engler JA
Crit Rev Oral Biol Med; 1993; 4(2):197-250. PubMed ID: 8435466
[TBL] [Abstract][Full Text] [Related]
5. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
[TBL] [Abstract][Full Text] [Related]
6. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A.
Menashi S; Vlodavsky I; Ishai-Michaeli R; Legrand Y; Fridman R
FEBS Lett; 1995 Mar; 361(1):61-4. PubMed ID: 7890041
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
9. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
[TBL] [Abstract][Full Text] [Related]
10. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging.
Vigetti D; Moretto P; Viola M; Genasetti A; Rizzi M; Karousou E; Pallotti F; De Luca G; Passi A
FASEB J; 2006 Jun; 20(8):1118-30. PubMed ID: 16770011
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.
Ye S; Humphries S; Henney A
Clin Sci (Lond); 1998 Feb; 94(2):103-10. PubMed ID: 9536917
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors in tumor progression.
De Clerck YA; Shimada H; Taylor SM; Langley KE
Ann N Y Acad Sci; 1994 Sep; 732():222-32. PubMed ID: 7978795
[No Abstract] [Full Text] [Related]
14. [Matrix metalloproteinase (MMP)].
Hornebeck W; Lafuma C
C R Seances Soc Biol Fil; 1991; 185(3):127-34. PubMed ID: 1835422
[TBL] [Abstract][Full Text] [Related]
15. Large inhibitor of metalloproteinases (LIMP) contains tissue inhibitor of metalloproteinases (TIMP)-2 bound to 72,000-M(r) progelatinase.
Curry VA; Clark IM; Bigg H; Cawston TE
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):143-7. PubMed ID: 1637293
[TBL] [Abstract][Full Text] [Related]
16. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A; Kolkenbrock H; Tschesche H
FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
[TBL] [Abstract][Full Text] [Related]
17. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
Sato H; Kinoshita T; Takino T; Nakayama K; Seiki M
FEBS Lett; 1996 Sep; 393(1):101-4. PubMed ID: 8804434
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury.
Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K
Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179
[TBL] [Abstract][Full Text] [Related]
19. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
20. Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.
Nagase H; Suzuki K; Itoh Y; Kan CC; Gehring MR; Huang W; Brew K
Adv Exp Med Biol; 1996; 389():23-31. PubMed ID: 8860990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
